?
LEVO-CTS
Cardiac Surgery
? ICUs
? patients
Cardiac surgery & LVEF < 35%: levo vs placebo, mortality, RRT, periop MI, mech
Clinical Question
In patients with LVEF <35% undergoing cardiac surgery does levosimenden
compared with placebo reduce the incidence of a composite outcome of: death
at day 30; renal replacement therapy at day 30; perioperative myocardial
infarct at day 5; and use of mechanical assist device at day 5
Critical Appraisal
- Population
- Surgical Patients
- Population Details
- Not recorded
- Intervention Arms
- Not recorded
- Control Arms
- Not recorded
- Primary Outcome
- Not recorded
- Secondary Outcomes
- Not recorded
- P Value
- Not recorded
Outcome Results
Not recorded